http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2405456-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc84cc2fddb226d30c8aed2e5e4802df |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B10-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate | 2009-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2010-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b7c6ad8c93e41862914a9a98667a5d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80b8e521f29f19783b265d7ffb80153c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b278fb20535b191304f32c597a535cc9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59173c471e88e15970667e6c9946eaed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e001e5b2449bdfdc8e94023e6ee9d3a |
| publicationDate | 2010-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2405456-C1 |
| titleOfInvention | Method of predicting course of wound process in case of purulent-inflammatory diseases of maxillofacial region of microbic etiology |
| abstract | FIELD: medicine. ^ SUBSTANCE: invention relates to field of medicine, namely to laboratory analysis and can be used for prediction of course of wound process in case of purulent-inflammatory diseases if maxillofacial region of microbial etiology. In carrying out microbiological analysis of wound discharge, presence or absence of microorganisms and their concentration are determined, in case of immunologic analysis registered are total number of leukocytes, ESR, levels of medium circulating immune complexes (CIC), antibodies to streptococcus (ASL-O), immunoglobulin A (IgA). Analysis is carried out befire and on 5-7 day after operation, and in case of complete elimination of microorganisms in wound or reduction of their concentration to <103 CFU/tamp., as well as reduction in blood serum for not less than 30% of total number of leukocytes, antibodies to streptococcus, and reduction for not less than 25% of value of ESR, CIC, IgA, favourable course of wound process is predicted, in case if indices are different - prediction is unfavourable. ^ EFFECT: method allows to reduce time of patient's hospitalisation, carry out adequate therapy in post-operational period in due time, does not require additional equipment for carrying out microbiological and immunological analysis. ^ 3 ex |
| priorityDate | 2009-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415966228 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439177 |
Total number of triples: 18.